Loading the records…
Loading the records…
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
National Institutes of Health wants bids for "Combined Synopsis Solicitation- Acquire Preventati". Bids are due Nov 23, 2026. In the last 2 years, similar work went to 10 or more companies, usually for about $95K per award. An award is expected around November 2026.
Put together from the facts on this page; the details and sources are below.
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Every notice posted under solicitation 75N98027Q00062 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
"equal" product must clearly identify the item by brand name (if any),make, and model number, and must provide sufficient descriptive literature and technicaldocumentation to demonstrate that the proposed product meets all salient physical, functional,and performance characteristics listed in Section (v) of this solicitation. Offers of "equal"products that fail to clearly identify the product or that fail to demonstrate compliance with thesalient characteristics may be rejected as non-responsive. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation forCommercial Products or Commercial Services, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks toaward a firm fixed-price to the responsible offeror whose proposal represents the best value tothe Government. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular March 2026.
16 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) J066.
Single-winner award sizes (16): middle half $43K to $239K, median $95K; range $14K to $696K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| AGILENT TECHNOLOGIES INC · $A · $7.4B | 3 | $445K | Jul 24, 2025 |
| BECTON, DICKINSON AND COMPANY · $BDX · $22.5B | 2 | $567K | Nov 19, 2025 |
| Revvity Health Sciences, Inc. | 1 | $696K | Sep 24, 2025 |
| MOLECULAR DEVICES LLC | 1 | $236K | Nov 22, 2024 |
| CTF MEG NEURO INNOVATIONS INC | 1 | $185K | Sep 9, 2025 |
| ETS-LINDGREN INC · $ESE · $1.3B | 1 | $157K | Sep 10, 2025 |
| HAMILTON COMPANY | 1 | $124K | May 6, 2025 |
| ILLUMINA, INC. · $ILMN · $4.5B | 1 | $65K | Sep 16, 2025 |
| NANOCELLECT BIOMEDICAL INC | 1 | $58K | Mar 20, 2025 |
| ABBERIOR INSTRUMENTS AMERICA LLC | 1 | $46K | Dec 11, 2024 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.